Pharmacokinetics and Effects of Neutron Capture on Melanoma Xenografts after Administration of Boronated Low Density Lipoprotein

  • Yohanes Setiawan
  • Michael D. Smith
  • Douglas E. Moore
  • Barry J. Allen


In this paper we confirm the retention of the physical characteristics and specific binding properties of low density lipoprotein (LDL) after extraction and reconstitution with a carborane compound. We also show that tumour uptake in vivo can be enhanced by downregulation of the LDL receptors in the liver and the adrenals, such that effective neutron capture therapy would be achievable with boronated LDL.


Boron Concentration Boron Neutron Capture Therapy Acute Myelogenous Leukemia Cell Neutron Capture Reaction Hydrocortisone Sodium Succinate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Y.K. Ho, R.G.Smith, M.S. Brown, and J.L. Goldstein, Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood, 52: 1099–1104, 1978.PubMedGoogle Scholar
  2. 2.
    R.A. Firestone, Low density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells, Bioconjugate Chem., 5: 105–113, 1994.CrossRefGoogle Scholar
  3. 3.
    S.B. Kahl and J.L Callaway, New tumour localizer: advances in the use of low density lipoproteins, Strahlenther. Onkol., 165: 137–140, 1989.PubMedGoogle Scholar
  4. 4.
    B.H. Laster, S.B. Kahl, E.A. Popenoe, D.W. Pate, and R.G. Fairchild, Biological efficacy of boronated low density lipoprotein for boron neutron capture therapy as measured in cell culture, Cancer Res., 51: 4588–4593, 1991.PubMedGoogle Scholar
  5. 5.
    S.B. Kahl, L.A. Wainschel, D.W. Pate, J.C. Callaway, and J. Hiltunen, In vitro and in vivo studies with boronated low density lipoproteins for neutron capture, in: “Clinic BNCT Workshop,” liro Autrinen and Merja Kallio. eds., Helsinki, 1993, pp. 105–109.Google Scholar
  6. 6.
    R.J. Havel, H.A. Eder, and J.H. Bragdon, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum., J. Clin. Invest., 34: 1345–1353, 1955.PubMedCrossRefGoogle Scholar
  7. 7.
    M. Masquelier, S. Vitols, and C. Peterson, Low-density lipoprotein as a carrier ofantitumoral drugs: In vivo fate of drug-human low-density lipoprotein complexes in mice, Cancer Res., 46: 3842–3847, 1986.PubMedGoogle Scholar
  8. 8.
    M.D. Smith, Y. Setiawan, and D.E. Moore, Optimisation of drug anchor for ortho-carborane in reconstitution of low density lipoproteins. (These proceedings) Google Scholar
  9. 9.
    Y. Setiawan, T. Rise, and D.E. Moore, Fourier transform infrared (FTIR) spectrometry for the assay of polyhedral boron compounds in plasma and pharmaceutical formulations, Pharmaceutical Res., 1 1:723727, 1994.Google Scholar
  10. 10.
    M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding, Anal. Biochem., 72: 248–254, 1976.PubMedCrossRefGoogle Scholar
  11. 11.
    S.S. Hynds, J. Welsh, J.M. Stewardt, A. Jack, M. Soukop, C.S. McArdle, K.C. Calman, C.J. Packard, and J. Shepherd, Low density lipoprotein metabolism in mice with soft tissue tumours. Biochimica ci Biophysica Acta, 795: 589–595, 1984.CrossRefGoogle Scholar
  12. 12.
    S.R. Tamat, D.E. Moore, and B.J. Allen, Assay of boron in biological tissues by inductively coupled plasma atomic emission spectrometry, Anal. Chem., 59: 2161 2164, 1987.Google Scholar
  13. 13.
    B.J. Allen, S. Corderoy-Buck, J.L. Mallesch, K. Crotty, and D.E. Moore, Local control of subcutaneous murine melanoma xenografts in nude mice by neutron capture therapy. Melanoma Res., 2: 253–262, 1992.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Yohanes Setiawan
    • 1
  • Michael D. Smith
    • 1
  • Douglas E. Moore
    • 1
  • Barry J. Allen
    • 1
    • 2
  1. 1.Department of PharmacyUniversity of SydneyAustralia
  2. 2.St George Cancer Care CentreKogarahAustralia

Personalised recommendations